Literature DB >> 11468957

Variant Creutzfeldt-Jakob disease: a summary of current scientific knowledge in relation to public health.

M B Coulthart1, N R Cashman.   

Abstract

The prion diseases pose unique scientific, medical, veterinary and regulatory challenges. Here, we summarize current information bearing on the natural history, pathobiology and epidemiology of these disorders and public policy responses to the potential threats to public health posed, particularly, by bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease (vCJD). Six years after the first case reports of vCJD, there is still no clear indication of the magnitude of the primary epidemic, or of the likelihood of lateral transmission of this untreatable disease by iatrogenic means, particularly by blood and blood products. However, the unsettling nature of the available evidence warrants prudence regarding public health policy and regulation, as well as a forward-looking approach to research.

Entities:  

Mesh:

Year:  2001        PMID: 11468957      PMCID: PMC81246     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  70 in total

1.  Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components.

Authors:  I MacGregor; J Hope; G Barnard; L Kirby; O Drummond; D Pepper; V Hornsey; R Barclay; H Bessos; M Turner; C Prowse
Journal:  Vox Sang       Date:  1999       Impact factor: 2.144

Review 2.  Laboratory diagnosis of variant Creutzfeldt-Jakob disease.

Authors:  J W Ironside; M W Head; J E Bell; L McCardle; R G Will
Journal:  Histopathology       Date:  2000-07       Impact factor: 5.087

Review 3.  A prion primer.

Authors:  N R Cashman
Journal:  CMAJ       Date:  1997-11-15       Impact factor: 8.262

4.  Human TSE disease--viral or protein only?

Authors:  B Chesebro
Journal:  Nat Med       Date:  1997-05       Impact factor: 53.440

5.  A novel progressive spongiform encephalopathy in cattle.

Authors:  G A Wells; A C Scott; C T Johnson; R F Gunning; R D Hancock; M Jeffrey; M Dawson; R Bradley
Journal:  Vet Rec       Date:  1987-10-31       Impact factor: 2.695

6.  Scrapie infectious agent is virus-like in size and susceptibility to inactivation.

Authors:  R G Rohwer
Journal:  Nature       Date:  1984 Apr 12-18       Impact factor: 49.962

7.  Ecosystems supporting clusters of sporadic TSEs demonstrate excesses of the radical-generating divalent cation manganese and deficiencies of antioxidant co factors Cu, Se, Fe, Zn. Does a foreign cation substitution at prion protein's Cu domain initiate TSE?

Authors:  M Purdey
Journal:  Med Hypotheses       Date:  2000-02       Impact factor: 1.538

8.  Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update.

Authors:  G A Wells; S A Hawkins; R B Green; A R Austin; I Dexter; Y I Spencer; M J Chaplin; M J Stack; M Dawson
Journal:  Vet Rec       Date:  1998-01-31       Impact factor: 2.695

9.  Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering.

Authors:  C L Masters; J O Harris; D C Gajdusek; C J Gibbs; C Bernoulli; D M Asher
Journal:  Ann Neurol       Date:  1979-02       Impact factor: 10.422

10.  Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain.

Authors:  A C Ghani; N M Ferguson; C A Donnelly; T J Hagenaars; R M Anderson
Journal:  Proc Biol Sci       Date:  1998-12-22       Impact factor: 5.349

View more
  9 in total

1.  Wild game feasts and fatal degenerative neurologic illness.

Authors:  John Hoey
Journal:  CMAJ       Date:  2003-09-02       Impact factor: 8.262

2.  Creutzfeldt-Jakob disease and infection control.

Authors:  L Johnston; J Conly
Journal:  Can J Infect Dis       Date:  2001-11

3.  Binding of bovine T194A PrP(C) by PrP(Sc)-specific antibodies: potential implications for immunotherapy of familial prion diseases.

Authors:  Claudia A Madampage; Pekka Määttänen; Kristen Marciniuk; Robert Brownlie; Olga Andrievskaia; Andrew Potter; Neil R Cashman; Jeremy S Lee; Scott Napper
Journal:  Prion       Date:  2013-05-31       Impact factor: 3.931

4.  Preoperative autologous blood donation reduces the need for allogeneic blood products: a prospective randomized study.

Authors:  Denis Bouchard; Bertrand Marcheix; Sfoug Al-Shamary; Frédéric Vanden Eynden; Philippe Demers; Danielle Robitaille; Michel Pellerin; Louis P Perrault; Michel Carrier
Journal:  Can J Surg       Date:  2008-12       Impact factor: 2.089

5.  Cell mediated immune responses against human prion protein.

Authors:  J Bainbridge; B Walker
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

6.  Creutzfeldt-Jakob disease mortality in Canada, 1998 to 2013.

Authors:  M B Coulthart; G H Jansen; T Connolly; R D'Amour; J Kruse; J Lynch; S Sabourin; Z Wang; A Giulivi; M N Ricketts; N R Cashman
Journal:  Can Commun Dis Rep       Date:  2015-08-06

7.  Detection and control of prion diseases in food animals.

Authors:  Peter Hedlin; Ryan Taschuk; Andrew Potter; Philip Griebel; Scott Napper
Journal:  ISRN Vet Sci       Date:  2012-02-29

8.  Nanopore analysis of wild-type and mutant prion protein (PrP(C)): single molecule discrimination and PrP(C) kinetics.

Authors:  Nahid N Jetha; Valentyna Semenchenko; David S Wishart; Neil R Cashman; Andre Marziali
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

Review 9.  Evidence for prion-like mechanisms in several neurodegenerative diseases: potential implications for immunotherapy.

Authors:  Kristen Marciniuk; Ryan Taschuk; Scott Napper
Journal:  Clin Dev Immunol       Date:  2013-10-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.